Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Ahlenstiel T, Sester M, Pape L (2012) Level of virus-specific T cells (Tvis) as an indicator of overimmunosuppression after pediatric kidney transplantation. Am J Transplant 12:160
2. Ahlenstiel-Grunow T et al (2014) A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)—specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial. Trials 15:324
3. Ahlenstiel-Grunow T et al (2021) Steering transplant immunosuppression by measuring virus-specific T cell levels: the randomized, controlled IVIST trial. J Am Soc Nephrol 32:502–516
4. Ahlenstiel-Grunow T et al (2021) Steering of immunosuppression by virus-specific T cells after pediatric kidney transplantation. Pediatr Nephrol 35:3308
5. Ahlenstiel-Grunow T, Pape L (2019) Epstein Barr virus (EBV)-specific T cells as a diagnostic marker for the individual EBV-specific immune response after pediatric kidney transplantation. Am J Transplant 19:465